Schepens Eye Research Institute of Massachusetts Eye and Ear, Department of Ophthalmology, Harvard Medical School, Boston, Massachusetts, United States.
Department of Ophthalmology, Pontificia Universidad Católica de Chile, Santiago, Chile.
Invest Ophthalmol Vis Sci. 2018 Jan 1;59(1):223-230. doi: 10.1167/iovs.17-23196.
Galectin-3 is a carbohydrate-binding protein known to promote expression of matrix metalloproteinases, a hallmark of ulceration, through interaction with the extracellular matrix metalloproteinase inducer CD147. The aim of this study was to investigate the distribution of galectin-3 in corneas of patients with ulcerative keratitis and to determine its relationship to CD147 and the presence of gelatinolytic activity.
This was an observational case series involving donor tissue from 13 patients with active corneal ulceration and 6 control corneas. Fixed-frozen sections of the corneas were processed to localize galectin-3 and CD147 by immunofluorescence microscopy. Gelatinolytic activity was detected by in situ zymography.
Tissue from patients with active corneal ulceration showed a greater galectin-3 immunoreactivity in basal epithelia and stroma compared with controls. Immunofluorescence grading scores revealed increased colocalization of galectin-3 and CD147 in corneal ulcers at the epithelial-stromal junction and within fibroblasts. Quantitative analysis using the Manders' colocalization coefficient demonstrated significant overlap in corneas from patients with ulcerative keratitis (M1 = 0.29; M2 = 0.22) as opposed to control corneas (M1 = 0.01, P < 0.01; M2 = 0.02, P < 0.05). In these experiments, there was a significant positive correlation between the degree of galectin-3 and CD147 colocalization and the presence of gelatinolytic activity.
Our results indicate that concomitant stimulation and colocalization of galectin-3 with CD147 are associated with increased gelatinolytic activity in the actively ulcerating human cornea and suggest a mechanism by which galectin-3 may contribute to the degradation of extracellular matrix proteins during ulceration.
半乳糖凝集素-3 是一种已知的糖结合蛋白,通过与细胞外基质金属蛋白酶诱导物 CD147 相互作用,促进基质金属蛋白酶的表达,这是溃疡的一个标志。本研究旨在研究半乳糖凝集素-3 在溃疡性角膜炎患者角膜中的分布,并确定其与 CD147 的关系以及明胶酶活性的存在。
这是一项观察性病例系列研究,涉及 13 例活动性角膜溃疡患者和 6 例对照角膜的供体组织。通过免疫荧光显微镜对角膜的固定冷冻切片进行半乳糖凝集素-3 和 CD147 的定位。通过原位酶谱法检测明胶酶活性。
与对照组相比,活动性角膜溃疡患者的组织在基底上皮和基质中显示出更强的半乳糖凝集素-3 免疫反应性。免疫荧光分级评分显示,在角膜溃疡上皮-基质交界处和纤维母细胞内,半乳糖凝集素-3 和 CD147 的共定位增加。使用 Manders 共定位系数的定量分析表明,与对照组相比,溃疡性角膜炎患者的角膜(M1 = 0.29;M2 = 0.22)有明显的重叠(M1 = 0.01,P <0.01;M2 = 0.02,P <0.05)。在这些实验中,半乳糖凝集素-3 和 CD147 共定位的程度与明胶酶活性的存在之间存在显著的正相关。
我们的研究结果表明,半乳糖凝集素-3 与 CD147 的同时刺激和共定位与人类活动性溃疡角膜中明胶酶活性的增加有关,并提示半乳糖凝集素-3 可能通过在溃疡过程中降解细胞外基质蛋白而发挥作用的机制。